Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
Nodes: 6555, Authors: 15733, Journals: 1105, Cited References: 140610, Words: 8620, Tags: 1
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
View: Overview | Sorted by GCS. |
# | Word | Pubs | TLCS | TGCS |
---|---|---|---|---|
401 | UPSTREAM | 14 | 282 | 882 |
402 | REVEALS | 23 | 489 | 872 |
403 | FORMED | 26 | 360 | 864 |
404 | SPECIES | 43 | 440 | 860 |
405 | EMBRYONIC | 21 | 429 | 859 |
406 | DELETION | 31 | 357 | 854 |
407 | SILENCERS | 5 | 230 | 853 |
408 | HTRT | 3 | 541 | 849 |
409 | LYMPHOCYTE | 16 | 477 | 847 |
410 | RESCUES | 5 | 693 | 844 |
411 | PAIRING | 21 | 176 | 843 |
412 | LESIONS | 28 | 420 | 842 |
413 | TELOMERE-ASSOCIATED | 22 | 459 | 838 |
414 | FOLDING | 15 | 216 | 837 |
415 | PROSTATE | 36 | 332 | 837 |
416 | INVOLVEMENT | 21 | 336 | 833 |
417 | PAPILLOMAVIRUS | 16 | 275 | 830 |
418 | CONTAINS | 19 | 342 | 828 |
419 | LEVELS | 20 | 494 | 826 |
420 | LINE | 64 | 346 | 822 |
421 | POLY | 23 | 227 | 819 |
422 | BASE-PAIRS | 13 | 450 | 815 |
423 | CONSTRUCTION | 14 | 185 | 815 |
424 | DIVERSITY | 12 | 89 | 815 |
425 | BENIGN | 28 | 335 | 813 |
426 | RIBOSOMAL-SUBUNIT | 5 | 22 | 810 |
427 | END-TO-END | 8 | 583 | 809 |
428 | PROGENITOR | 14 | 441 | 807 |
429 | ARABIDOPSIS | 31 | 406 | 806 |
430 | AUTONOMOUSLY | 10 | 170 | 804 |
# | Word | Pubs | TLCS | TGCS |
431 | DETECTABLE | 5 | 562 | 803 |
432 | GERMLINE | 16 | 476 | 799 |
433 | TRANSLATIONAL | 7 | 53 | 794 |
434 | SINGLE | 27 | 496 | 790 |
435 | VIRUSES | 9 | 10 | 786 |
436 | COMPILATION | 5 | 21 | 784 |
437 | REVERSIBLE | 6 | 223 | 784 |
438 | CLINICAL | 48 | 342 | 783 |
439 | SOMATIC | 33 | 387 | 782 |
440 | AGENTS | 23 | 370 | 779 |
441 | NUCLEOTIDE | 13 | 109 | 779 |
442 | DRUG | 22 | 370 | 777 |
443 | HUMAN-CELLS | 3 | 496 | 776 |
444 | CHROMOSOME-III | 6 | 46 | 774 |
445 | POSSIBLE | 36 | 243 | 772 |
446 | TETRADS | 10 | 334 | 770 |
447 | ALTERATION | 19 | 617 | 767 |
448 | HETEROCHROMATIN | 23 | 218 | 765 |
449 | GUANINE-RICH | 13 | 363 | 763 |
450 | TUMORIGENESIS | 19 | 378 | 763 |
451 | HIGH-DENSITY | 1 | 4 | 762 |
452 | POTATO | 1 | 4 | 762 |
453 | COMPARISON | 36 | 157 | 761 |
454 | CRYSTAL | 14 | 285 | 755 |
455 | PROLIFERATIVE | 15 | 428 | 754 |
456 | BONE | 32 | 319 | 753 |
457 | OVERHANG | 15 | 576 | 752 |
458 | CATALYZED | 4 | 30 | 751 |
459 | BASE | 21 | 134 | 749 |
460 | CONGENITA | 26 | 488 | 749 |
# | Word | Pubs | TLCS | TGCS |
461 | DYSKERATOSIS | 26 | 488 | 749 |
462 | TRANSLATION | 6 | 53 | 747 |
463 | LESSONS | 12 | 66 | 743 |
464 | RAPID | 37 | 283 | 739 |
465 | MUTATED | 9 | 641 | 738 |
466 | REQUIRES | 17 | 478 | 737 |
467 | DNA-STRUCTURE | 8 | 258 | 733 |
468 | HYBRIDIZATION | 50 | 274 | 732 |
469 | IN-VIVO | 8 | 348 | 732 |
470 | BOMB | 1 | 508 | 731 |
471 | CHANGES | 47 | 333 | 730 |
472 | SMALL-SUBUNIT | 7 | 54 | 730 |
473 | SWITCH | 10 | 334 | 729 |
474 | VARIABILITY | 12 | 493 | 728 |
475 | TAILS | 8 | 561 | 723 |
476 | ASSEMBLY | 27 | 403 | 717 |
477 | DNA-MOLECULES | 10 | 541 | 717 |
478 | DIFFERENCES | 10 | 202 | 714 |
479 | INTRON | 10 | 112 | 714 |
480 | PLANT | 35 | 339 | 713 |
481 | STABLE | 23 | 116 | 712 |
482 | RESULT | 13 | 400 | 709 |
483 | FIBROBLAST | 14 | 173 | 707 |
484 | RAT | 35 | 326 | 706 |
485 | DEAFNESS | 6 | 25 | 704 |
486 | INTERSTITIAL | 17 | 294 | 703 |
487 | PARAMECIUM | 48 | 304 | 703 |
488 | OLIGONUCLEOTIDE | 23 | 251 | 702 |
489 | SPONTANEOUS | 16 | 256 | 701 |
490 | MAINTAINING | 6 | 460 | 699 |
# | Word | Pubs | TLCS | TGCS |
491 | TERMINUS | 11 | 592 | 698 |
492 | JOINING | 8 | 188 | 697 |
493 | EXTENDED | 8 | 360 | 695 |
494 | SPAN | 14 | 398 | 695 |
495 | RESTRICTION | 15 | 99 | 693 |
496 | LYMPHOCYTES | 35 | 367 | 692 |
497 | POL-II | 1 | 208 | 692 |
498 | CIRCULAR | 23 | 224 | 689 |
499 | G-RICH | 14 | 481 | 689 |
500 | THERAPY | 41 | 289 | 687 |
501 | COMMON | 21 | 223 | 686 |
502 | INTERACTS | 14 | 441 | 684 |
503 | PHYSICAL | 19 | 86 | 676 |
504 | CHEMISTRY | 8 | 47 | 670 |
505 | MAPPING | 43 | 182 | 668 |
506 | URINE | 18 | 252 | 667 |
507 | CODING | 12 | 180 | 664 |
508 | DIAGNOSIS | 27 | 242 | 664 |
509 | CERVICAL | 22 | 272 | 660 |
510 | HETEROGENEITY | 16 | 385 | 660 |
511 | POLYMORPHISM | 23 | 297 | 659 |
512 | C-MYC | 25 | 198 | 657 |
513 | PLANTS | 13 | 199 | 657 |
514 | PROPOSAL | 3 | 6 | 657 |
515 | CILIATED | 12 | 307 | 654 |
516 | ENDOTHELIAL | 37 | 263 | 650 |
517 | BROKEN | 11 | 385 | 646 |
518 | TYPES | 9 | 419 | 645 |
519 | BIOLOGICAL | 30 | 182 | 644 |
520 | TRYPANOSOMA | 21 | 109 | 644 |
# | Word | Pubs | TLCS | TGCS |
521 | SELECTIVE | 23 | 357 | 641 |
522 | TEL | 15 | 319 | 641 |
523 | HUMAN-CHROMOSOME | 4 | 423 | 639 |
524 | SENSITIVITY | 19 | 320 | 637 |
525 | ANALYSES | 11 | 50 | 635 |
526 | SWITCHING | 8 | 506 | 631 |
527 | MARKER | 19 | 272 | 628 |
528 | HYPOTHESIS | 14 | 336 | 627 |
529 | ACTIVATING | 4 | 88 | 626 |
530 | POLYMORPHIC | 7 | 97 | 625 |
531 | RESULTS | 14 | 391 | 623 |
532 | PREVENTING | 2 | 27 | 622 |
533 | LOOPS | 6 | 303 | 621 |
534 | NEUROBLASTOMA | 6 | 402 | 621 |
535 | LEUKOCYTES | 3 | 464 | 619 |
536 | OPTIMAL | 1 | 5 | 617 |
537 | END-JOINING | 5 | 232 | 616 |
538 | KERATINOCYTES | 16 | 363 | 616 |
539 | EVOLUTIONARILY | 10 | 287 | 615 |
540 | PROTOCOL | 13 | 350 | 615 |
541 | TREATMENT | 40 | 283 | 615 |
542 | TURNOVER | 14 | 257 | 615 |
543 | ADOPTED | 5 | 117 | 614 |
544 | HTR | 21 | 382 | 613 |
545 | TELOMERASE-DEFICIENT | 15 | 374 | 613 |
546 | VARIANT | 18 | 115 | 611 |
547 | SUPPRESSION | 24 | 114 | 608 |
548 | BASED | 21 | 121 | 607 |
549 | KINASES | 5 | 108 | 605 |
550 | NOVA | 16 | 333 | 605 |
# | Word | Pubs | TLCS | TGCS |
551 | ACCUMULATION | 11 | 280 | 604 |
552 | MONO-VALENT | 1 | 329 | 604 |
553 | SURFACE | 26 | 110 | 602 |
554 | NUCLEOLAR | 15 | 276 | 601 |
555 | EFFICIENT | 15 | 246 | 600 |
556 | RNA-LIKE | 6 | 144 | 600 |
557 | STEM-CELLS | 2 | 303 | 600 |
558 | FUSION | 19 | 222 | 599 |
559 | PROBLEM | 9 | 464 | 598 |
560 | DESIGN | 14 | 272 | 597 |
561 | CULTURE | 20 | 223 | 594 |
562 | LIVER | 21 | 221 | 594 |
563 | DNAS | 19 | 181 | 593 |
564 | MARROW | 22 | 246 | 592 |
565 | PRESENCE | 17 | 209 | 592 |
566 | STABILIZATION | 17 | 300 | 592 |
567 | CHRONIC | 32 | 250 | 591 |
568 | REACTION | 15 | 166 | 591 |
569 | COOPERATES | 5 | 380 | 590 |
570 | ENDONUCLEASES | 6 | 18 | 590 |
571 | INVERTED | 17 | 261 | 590 |
572 | DNA-POLYMERASES | 2 | 37 | 589 |
573 | POTENT | 18 | 369 | 589 |
574 | TRANSLOCATIONS | 8 | 221 | 589 |
575 | UNIQUE | 14 | 251 | 588 |
576 | LOCI | 11 | 104 | 584 |
577 | DELETIONS | 19 | 234 | 583 |
578 | QUADRUPLEXES | 26 | 258 | 583 |
579 | STAGE | 16 | 244 | 582 |
580 | MRNA | 48 | 269 | 581 |
# | Word | Pubs | TLCS | TGCS |
581 | NATURAL | 20 | 325 | 581 |
582 | INFECTION | 24 | 134 | 580 |
583 | WERNER | 13 | 176 | 579 |
584 | ANTISENSE | 29 | 274 | 578 |
585 | TELOMERASE-ASSOCIATED | 9 | 387 | 578 |
586 | EUPLOTES-CRASSUS | 13 | 413 | 577 |
587 | ACQUISITION | 5 | 364 | 576 |
588 | GENETICS | 21 | 117 | 576 |
589 | CONDENSATION | 9 | 19 | 575 |
590 | OVARIAN-CARCINOMA | 1 | 439 | 575 |
591 | REGULATOR | 12 | 389 | 575 |
592 | SURVIVAL | 24 | 312 | 575 |
593 | BEGINNING | 4 | 417 | 574 |
594 | HISTONE | 22 | 98 | 574 |
595 | FREQUENCY | 16 | 108 | 573 |
596 | LONGEVITY | 15 | 248 | 573 |
597 | NMR | 22 | 122 | 573 |
598 | ALPHA | 28 | 279 | 570 |
599 | CLEAVAGE | 18 | 296 | 570 |
600 | OCCURS | 14 | 282 | 570 |